SUMMARY A toxin produced by Clostridium difficile has been implicated in the pathogenesis of antibiotic-associated colitis in humans and experimental animals. This study was undertaken in order to define the sequential evolution of caecal mucosal lesions in the hamster and to relate those lesions directly to the clostridial toxin. Sterile filtrates from a culture of C. difficile and from caecal contents of clindamycin-treated hamsters were studied with respect to their effects on the caecal mucosa and on cultured cell monolayers. The toxic filtrates both produced cellular swelling in vitro, and appeared to have a similar cytotoxic effect on caecal epithelial cells in vivo. Cellular damage was followed by extensive epithelial desquamation and the evolution of an acute pseudomembranous typhlitis. The pathogenetic sequence produced by the filtrates was identical with that previously described after direct clindamycin treatment. These findings demonstrate that intraluminal clostridial toxin can mediate development of the characteristic antibiotic-associated mucosal lesions.
Pseudomembranous colitis, first recognized many decades ago, has been described in a variety of clinical settings, but especially in association with the administration of antibiotics.' 2 Recently, hamsters treated with clindamycin have provided an excellent model of antibiotic-associated pseudomembranous colitis in humans.3 6 In this model, as well as in human cases, a toxin of clostridial origin has been identified3 7-12; and microbiological studies have implicated Clostridium difficile as the responsible organism.31315 These converging lines of evidence suggest that antibiotic treatment alters the intestinal microflora in such a way as to allow C. difficile to flourish and produce a toxin which, in turn, may be responsible for the development of the mucosal lesions.
In the hamster, typhlitis has been produced by intracaecal injection of filtrates derived from caecal contents of clindamycin-treated animals,'6 and by injection of stools from human patients with antibiotic-associated pseudomembranous colitis. (Fig. 1) .
ANIMALS INJECTED WITH TOXIC FILTRATES
The sequence of caecal mucosal changes produced by the culture filtrate of C. difficile precisely paralleled that produced by the stool filtrate from clindamycintreated hamsters. In both instances, the evolving histological pattern reflected the direct action of an injurious substance on the surface epithelium of the caecal mucosa, leading to a diffuse typhlitis with inflammatory pseudomembranes. The following description of evolving mucosal lesions applies both to stool filtrate and culture filtrate.
The caecal mucosa was histologically normal for the first hour after injection. Between 60 and 90 minutes, surface epithelial cells between crypts developed cytoplasmic vacuolation which progressed in extent during the 21 to 31 hour interval. This cytological change was most pronounced in epithelial cells closest to the lumen, while more deeply situated crypt epithelial cells were generally not involved (Fig. 2) . This epithelial abnormality was not seen in animals receiving filtrates neutralised with antitoxin.
When the epithelial vacuolation first appeared, the lamina propria remained normal. Between 21 and four hours, purulent inflammation began to appear in areas of severe epithelial damage, particularly in the 'summits' between crypts (Fig. 3) . At four hours, surface epithelial cells were severely distorted, ballooned, and beginning to desquamate into the lumen in small clusters or vertically oriented ridges. Adjacent areas of the mucosa were often surfaced by flattened epithelial cells which appeared to be spreading as neighbouring cells desquamated. The lamina propria of these damaged mucosae appeared congested, and increasing purulent inflammation was evident.
These epithelial changes and the associated inflammatory reaction evolved at a somewhat variable pace over the next several hours. By eight hours after injection, a severe diffuse typhlitis was evident in all animals. Some parts of the mucosa were surfaced by an attenuated epithelium which extended beneath clusters and ridges of damaged, desquamating epithelial cells mixed with purulent exudate (Fig. 4) . In other areas, superficial portions of the mucosa were necrotic and sloughing, and the surface was covered by an inflammatory pseudomembrane (Fig. 5) . Scanning electron microscopy revealed changes in mucosal topography corresponding to those seen in light microscopy. In control animals, the caecal mucosal surface was smooth and regular, with an even microvillous pattern (Fig. 6) . In animals injected with toxic filtrates, the earliest recognisable change consisted of apparent swelling of surface epithelial cells, which became more convex and more sharply demarcated at lines of intercellular junction than in the corresponding control mucosae (Fig. 7) . As the lesions progressed, crypts were dilated and the intercryptal 'summit' regions were ridged with severely distorted, desquamating epithelial cells (Fig. 8) . Finally, topographical features were obscured by overlying necrotic debris and inflammatory exudate.
CV-1 MONKEY KIDNEY CELLS EXPOSED in vitro TO TOXIC FILTRATES
Scanning electron microscopy of cells exposed in vitro to faecal and culture filtrates supported the inference, drawn from the above observations, that these filtrates contain a toxin which is capable of injuring cells directly. Control cells were smooth surfaced and relatively flat, while those exposed to the filtrates developed an irregular contour and became ballooned, much as did the caecal epithelial cells (Figs. 9 and 10 ).
Discussion
Recent investigations have documented the presence of C. difficile and its toxin in the faeces of patients with antibiotic-associated pseudomembranous colitis.13-15 However, evidence linking the toxin directly to the pathogenesis of the human colitic lesion has, of necessity, been incomplete. The clindamycin-treated hamster has proved, in the hands of several groups of investigators, to be a useful model for the study of this disease.356 In our own laboratory, the sequence of studies began with the discovery of a toxin in the stools of patients with antibiotic-associated colitis, confirming the original report of Larson.7 9 The toxin, which was lethal for hamsters when injected intraperitoneally, and which was directly toxic to cultured cells, could be neutralised by C. sordellii antitoxin. Turning to the clindamycin-treated hamster, we characterised the intestinal lesions by light and scanning electron microscopy, and found them to be associated with an increase in C. sordellii and C. difficile in the faeces.4 Vancomycin was found to prevent these clindamycin-induced lesions."8 Subsequently, it was found that a toxic substance was present in the faeces of clindamycin-treated hamsters which was lethal to other hamsters and cytotoxic in tissue culture. The toxic effects were neutralised by in vitro incubation with polyvalent clostridial antitoxin.'0 Next it was found that neutralisation of the hamster toxin could be accomplished with C. sordellii antitoxin, and that the antitoxin would neutralise the toxicity of culture filtrates of C. difficile as well as C. sordellii.1" The former organism appeared more likely to be responsible for the disease produced by clindamycin. Finally, it was recently demonstrated in our laboratory that passive immunisation of the hamster with C. sordellii antitoxin is protective against clindamycin-associated colitis.12 The mechanism by which the toxin acts on the mucosa is largely unknown, and the details of histogenesis have not been reported heretofore.
In the studies reported here, filtrates of caecal content from clindamycin-treated animals and culture filtrates of C. difficile, upon intracaecal injection, produced a severe, diffuse typhlitis. The evolving lesions were indistinguishable from those seen in clindamycin-treated animals by light and scanning electron microscopy.45 The earliest detectable lesion produced by the toxic filtrates was a striking epithelial swelling and vacuolation which occurred in the absence of other mucosal abnormalities. This, taken in conjunction with the superficial location of the affected cells, is most consistent with the effects of a luminal toxin acting directly on epithelium. That the toxin can indeed produce such direct effects is shown by the results of our tissue culture studies, and those of others.
In vitro cytotoxicity has been demonstrated with faeces from patients7 and experimental animals3 with antibiotic-associated colitis. The results of a recent study suggest that one of the main effects of C. difficile toxin is modification of the cell membrane.'9 A similar pattern of direct toxic effects on superficial intestinal epithelium has been reported for another clostridium, C. perfringens.20
Epithelial cells injured by the toxin desquamate rapidly, sometimes en masse, and an acute inflammatory reaction evolves in the subjacent lamina propria. The thinning and flattening of epithelium next to the masses of desquamating cells most probably represents early reparative migration of less damaged cells. At the peak of development of the typhlitis, epithelial loss becomes sufficiently massive for mucosal continuity to be lost, and the surface is coated by an inflammatory pseudomembrane.
Thus, our entire series of studies of the experimental hamster model, in agreement with abundant evidence adduced by others 51316 supports and extends the evidence derived from human cases. Clindamycin-treatment is associated with the growth of C. difficile in the intestine and with the production of toxin by the organism. The intraluminal toxin mediates the development of the characteristic mucosal lesions. 
